PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,563,000 | +88.0% | 72,484 | +22.6% | 0.02% | +91.7% |
| Q2 2018 | $1,895,000 | +11.8% | 59,114 | +8.6% | 0.01% | -7.7% |
| Q1 2018 | $1,695,000 | -17.4% | 54,413 | +21.0% | 0.01% | -7.1% |
| Q4 2017 | $2,052,000 | +37.5% | 44,956 | +13.2% | 0.01% | +27.3% |
| Q3 2017 | $1,492,000 | -13.6% | 39,731 | +9.8% | 0.01% | -8.3% |
| Q2 2017 | $1,726,000 | +17.7% | 36,185 | +12.5% | 0.01% | +20.0% |
| Q1 2017 | $1,467,000 | +26.4% | 32,177 | -10.5% | 0.01% | +11.1% |
| Q4 2016 | $1,161,000 | -28.6% | 35,943 | -24.4% | 0.01% | -30.8% |
| Q3 2016 | $1,626,000 | -7.7% | 47,524 | -9.0% | 0.01% | -18.8% |
| Q2 2016 | $1,761,000 | -20.2% | 52,212 | +25.3% | 0.02% | -30.4% |
| Q1 2016 | $2,208,000 | -40.6% | 41,670 | -13.9% | 0.02% | -36.1% |
| Q4 2015 | $3,718,000 | -84.2% | 48,422 | -15.6% | 0.04% | +44.0% |
| Q3 2015 | $23,575,000 | +821.6% | 57,360 | +58.6% | 0.02% | +13.6% |
| Q2 2015 | $2,558,000 | +59.7% | 36,170 | +100.6% | 0.02% | +69.2% |
| Q1 2015 | $1,602,000 | – | 18,035 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |